HPA041402

antibody from Atlas Antibodies

Targeting: CARMIL2 LRRC16C, RLTPR

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

HPA041402

Provider

Atlas Antibodies

Proper citation

Atlas Antibodies Cat#HPA041402, RRID:AB_10795591

Product name

Anti-CARMIL2

Antibody type

Polyclonal

Description

Polyclonal Antibody against Human CARMIL2, Gene description: capping protein regulator and myosin 1 linker 2, Alternative Gene Names: LRRC16C, RLTPR, Validated applications: IHC, Uniprot ID: Q6F5E8, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

100 µl

Concentration

0.1 mg/ml

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Handling

The antibody solution should be gently mixed before use.

References

Submitted references

Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease

Bosa L, Batura V, Colavito D, Fiedler K, Gaio P, Guo C, Li Q, Marzollo A, Mescoli C, Nambu R, Pan J, Perilongo G, Warner N, Zhang S, Kotlarz D, Klein C, Snapper S, Walters T, Leon A, Griffiths A, Cananzi M, Muise A
Scientific Reports 2021;11(1)

---

CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease

Magg T, Shcherbina A, Arslan D, Desai M, Wall S, Mitsialis V, Conca R, Unal E, Karacabey N, Mukhina A, Rodina Y, Taur P, Illig D, Marquardt B, Hollizeck S, Jeske T, Gothe F, Schober T, Rohlfs M, Koletzko S, Lurz E, Muise A, Snapper S, Hauck F, Klein C, Kotlarz D
Inflammatory Bowel Diseases 2019;25(11):1788-1795

---

A human immunodeficiency syndrome caused by mutations in CARMIL2

Schober T, Magg T, Laschinger M, Rohlfs M, Linhares N, Puchalka J, Weisser T, Fehlner K, Mautner J, Walz C, Hussein K, Jaeger G, Kammer B, Schmid I, Bahia M, Pena S, Behrends U, Belohradsky B, Klein C, Hauck F
Nature Communications 2017;8(1)